Predict your next investment

HEALTHCARE | Medical Devices & Equipment / Patient Monitoring

See what CB Insights has to offer

Total Raised

$57.91M

Investors Count

16

Deal Terms

2

LXN Corporation Funding, LXN Corporation Valuation & LXN Corporation Revenue

8 Fundings

LXN Corporation's latest funding round was a Acquired for on March 9, 2001.

LXN Corporation's valuation in July 1997 was $51.76M.

LXN Corporation's latest post-money valuation is from March 2001.

Sign up for a free trial to see LXN Corporation's valuations in March 2001 and more.

Date

Round

Amount

Investors

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Revenue

Sources

3/9/2001

Acquired

$99M

10/1/2000

Series C

$99M

0

3/23/1999

Unattributed VC - II

$99M

0

1/21/1998

Unattributed VC

$99M

0

7/1/1997

Series B

$99M

$51.76M

0

Date

3/9/2001

10/1/2000

3/23/1999

1/21/1998

7/1/1997

Round

Acquired

Series C

Unattributed VC - II

Unattributed VC

Series B

Amount

$99M

$99M

$99M

$99M

Investors

Valuation

$99M

$51.76M

Revenue

Sources

0

0

0

0

LXN Corporation Deal Terms

2 Deal Terms

LXN Corporation's deal structure is available for 2 funding rounds, including their Acquired from March 09, 2001.

Round

Acquired

Series B

Funding Date

$99M

$99M

Pre-Money Valuation

Post-Money Valuation

$99M

Amount Raised

$99M

Shares Authorized

Issuance Price

Dividend Rate

Liquidation Preferences

Liquidation Price

Participation

Conversion Price

Anti Dilution

General Voting

$99M

$99M

Board Voting

$99M

$99M

Par Value

Round

Funding Date

Pre-Money Valuation

Post-Money Valuation

Amount Raised

Shares Authorized

Issuance Price

Dividend Rate

Liquidation Preferences

Liquidation Price

Participation

Conversion Price

Anti Dilution

General Voting

Board Voting

Par Value

Acquired

$99M

$99M

$99M

$99M

Series B

$99M

$99M

$99M

$99M

LXN Corporation Investors

16 Investors

LXN Corporation has 16 investors. Diabetes Diagnostics invested in LXN Corporation's Acquired funding round.

First funding

Last Funding

Investor

Rounds

Board Seats

Type

Location

3/9/2001

3/9/2001

1
Acquired

1/21/1998

3/23/1999

2
Unattributed VC, Unattributed VC - II (1999)

Venture Capital

California

1/21/1998

3/23/1999

2
Unattributed VC, Unattributed VC - II (1999)

Private Equity

Massachusetts

00/00/0000

00/00/0000

Walden Venture Capital

Subscribe to see more

Venture Capital

California

00/00/0000

00/00/0000

Veron International

Subscribe to see more

Asset/Investment Management

Hong Kong

First funding

3/9/2001

1/21/1998

1/21/1998

00/00/0000

00/00/0000

Last Funding

3/9/2001

3/23/1999

3/23/1999

00/00/0000

00/00/0000

Investor

Walden Venture Capital

Veron International

Rounds

1
Acquired
2
Unattributed VC, Unattributed VC - II (1999)
2
Unattributed VC, Unattributed VC - II (1999)

Subscribe to see more

Subscribe to see more

Board Seats

Type

Venture Capital

Private Equity

Venture Capital

Asset/Investment Management

Location

California

Massachusetts

California

Hong Kong

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.